Macular & Diabetic Retinopathy

Service Description

iPSC technology may enable the generation of retinal cells, including photoreceptors and supporting cells, that could potentially replace those damaged or dysfunctional in macular degeneration and diabetic retinopathy. However, the therapeutic potential of such iPSC-based cell therapies for these eye diseases requires further preclinical and clinical investigation.